Max Robotics — Global Service Robot Directory + US Certification

About

Takanari Kambe is a urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques, particularly robot-assisted procedures, for the treatment of urologic cancers and congenital anomalies. His primary research areas include optimizing outcomes in robot-assisted partial nephrectomy (RAPN) for renal tumors, refining neoadjuvant chemohormonal therapy strategies for high-risk prostate cancer, and developing novel surgical approaches for complex urologic conditions. Kambe’s major contributions include demonstrating that renal sinus protrusions significantly impact the achievement of “trifecta” outcomes—a composite of negative surgical margins, no complications, and minimal renal function loss—in RAPN, with his 2023 study on this topic accumulating 4 citations. He has also shown that dose compliance of neoadjuvant estramustine phosphate combined with degarelix acetate predicts biochemical recurrence in very high-risk prostate cancer patients undergoing robot-assisted radical prostatectomy, a finding with 4 citations. Additionally, Kambe has pioneered a transvesical bladder diverticulectomy technique performed during robot-assisted radical prostatectomy and reported the first cases of robot-assisted reconstruction for retrocaval ureter. His work, with over 15 total citations, directly informs surgical decision-making and improves oncologic outcomes for patients with complex urologic diseases.